Posts In: Gubba Pharma In E News

Hyderabad will be medical devices hub soon: KTR

September 11, 2019 Gubba Pharma In E News

TRS working president KT Rama Rao on Saturday welcomed Surat-based medical devices manufacturer Sahajanand Medical Technologies (SMT), which is a leading manufacturer of coronary stents,...

Continue Reading

Glenmark Pharma gets USFDA nod for skin treatment ointment

September 11, 2019 Gubba Pharma In E News

Glenmark Pharmaceuticals has received final approval from the US health regulator for Pimecrolimus Cream, used to treat skin conditions such as eczema. The approved product...

Continue Reading

Alembic Pharmaceuticals gets USFDA nod for ophthalmic solution

September 11, 2019 Gubba Pharma In E News

The approved product is therapeutically equivalent to the reference listed drug (RLD), Bromday Ophthalmic Solution, 0.09 percent, of Bausch & Lomb. Drug firm Alembic Pharmaceuticals...

Continue Reading

FDA approves Keytruda as treatment for specific type of esophageal cancer

August 28, 2019 Gubba Pharma In E News

The U.S. Food and Drug Administration (FDA) has approved a new treatment option for patients with advanced esophageal cancer — the immunotherapy drug pembrolizumab, known...

Continue Reading

DSV-Panalpina merger creates world’s second largest airfreight forwarder

August 28, 2019 Gubba Pharma In E News

DSV has announced that its acquisition of Panalpina will finally be completed in a deal worth $5.5bn. The combined company will be recognised as DSV...

Continue Reading

Biocon’s Malaysia arm gets good manufacturing certificate from EU regulator

August 28, 2019 Gubba Pharma In E News

Biocon Ltd’s Malaysian subsidiary has received the Certificate of Good Manufacturing Practice (cGMP) compliance from the European drug regulator for its integrated insulin facility, helping...

Continue Reading

Novartis wins EU approval for blood cancer therapy Kymriah

August 21, 2019 Gubba Pharma In E News

Novartis has received European approval for Kymriah, its gene-modifying therapy for blood cancer, but said its introduction would vary from country to country as the...

Continue Reading

Alembic Pharmaceuticals gets USFDA nod for ophthalmic solution

August 21, 2019 Gubba Pharma In E News

The approved product is therapeutically equivalent to the reference listed drug (RLD), Bromday Ophthalmic Solution, 0.09 percent, of Bausch & Lomb. Drug firm Alembic Pharmaceuticals...

Continue Reading

Pharma Cold Storage: Indian Scenario

August 16, 2019 Gubba Pharma In E News

The pharmaceutical supply chain situation in India is extremely complex due to the complex supply chain environment along with the presence of more than 55,000...

Continue Reading